Description
UPTRAVI 200MCG/800MCG PRESCRIPTION REFILL
First action · last action
2019-04-26 · 2020-07-15
Transactions
3
First transaction's obligation
$246,308
Base + all options value (sum of deltas)
$206,573
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5160B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-04-26+$246,308= $246,308
- Mod P000012020-05-20+$0= $246,308
- Mod P000022020-07-15-$39,735= $206,573
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-04-26 | +$246,308 | $246,308 | UPTRAVI 200MCG/800MCG PRESCRIPTION REFILL |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-05-20 | +$0 | $246,308 | UPTRAVI 200MCG/800MCG PRESCRIPTION REFILL |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-07-15 | −$39,735 | $206,573 | UPTRAVI 200MCG/800MCG PRESCRIPTION REFILL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H5BMHLMMNA28)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0477 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $47,052 | FY2026 |
| 36C24526N0181 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,235 | FY2026 |
| 36C26026F0017 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $406,538 | FY2026 |
| 36C26026F0024 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $65,500 | FY2026 |
| 36C26025F0209 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $197,168 | FY2025 |
| 36C26025F0107 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $70,630 | FY2025 |
Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0328 | CARDINAL HEALTH 414, LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $999,797 | FY2026 |
| 36C24126F0121 | MCKESSON CORPORATION | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $16,333 | FY2026 |
| 36C24126F0112 | VANTIVE US HEALTHCARE LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $545,567 | FY2026 |
| 36C24126N0603 | AMERICAN NATIONAL RED CROSS, THE | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $1,998,719 | FY2026 |
| 36C24126F0109 | BOSTON SCIENTIFIC CORP | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $304,950 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24119N0588_3600_V797P5160B_3600 · retrieved 2026-09-26.